Search - tctmd.com

Displaying 81 - 95 of 95

Sort: Relevancy | Date

Presentation

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

Presenter: A. Wittfeldt

January 08, 2013

Presentation

Reduction in First and Recurrent Cardiovascular Events with Ticagrelor vs. Clopidogrel

Presenter: P. Kohli

January 06, 2013

Presentation

Randomized Assessment of Ticagrelor vs. Prasugrel: Antiplatelet Effects in Patients with STEMI

Presenter: Dimitrios Alexopoulos

December 03, 2012

Presentation TCT 2012

Debate: Prasugrel or Ticagrelor Should be Used in Nearly All Cases!

Presenter: Dominick Angiolillo

October 25, 2012

Presentation TCT 2012

Ticagrelor Update: PLATO: Recent Analyses

Presenter: Robert Harrington

October 24, 2012

Presentation TCT 2012

Ticagrelor Is the Right Choice: More Potent, Better Data!

Presenter: Dimitrios Alexopoulos

October 24, 2012

Presentation TCT 2012

Pro: Ticagrelor!

Presenter: David Kong

October 23, 2012

Presentation

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Presenter: Christoph Varenhorst

September 26, 2012

Presentation

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Presenter: Jan H. Cornel

August 02, 2012

Presentation

Ticagrelor vs. Prasugrel in ACS Patients with High On-Clopidogrel Platelet Reactivity Following PCI

Presenter: Dimitrios Alexopoulos

July 09, 2012

Presentation

Cost-Effectiveness of Treating ACS Patients with Ticagrelor for 12 Months

Presenter: Elisabet Nikolic

June 25, 2012

Presentation

Ticagrelor vs. Clopidogrel in Patients with ACS and a History of Stroke or TIA

Presenter: Stefan K. James

May 31, 2012

Presentation

Association of PPI Use and Cardiovascular Outcomes with Clopidogrel and Ticagrelor

Presenter: Shaun G. Goodman

January 24, 2012

Presentation

Relaciones entre el uso de IBP y Desenlaces Cardiovasculares con Clopidogrel y Ticagrelor

Presenter: Shaun G. Goodman

January 24, 2012

Presentation TCT 2012

Ticagrelor Enhances Adenosine-induced Coronary Vasodilatory Responses in Humans—a Randomised, Double-Blind, Placebo-Controlled, Crossover, Single Centre Study Using...

Presenter: Li-Ming Gan, Ann Wittfeldt, H?kan Emanuelsson, Sven Nylander, Magnus Andersson

January 03, 2012

Advertisement

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

Reduction in First and Recurrent Cardiovascular Events with Ticagrelor vs. Clopidogrel

Randomized Assessment of Ticagrelor vs. Prasugrel: Antiplatelet Effects in Patients with STEMI

Debate: Prasugrel or Ticagrelor Should be Used in Nearly All Cases!

Ticagrelor Update: PLATO: Recent Analyses

Ticagrelor Is the Right Choice: More Potent, Better Data!

Pro: Ticagrelor!

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Ticagrelor vs. Prasugrel in ACS Patients with High On-Clopidogrel Platelet Reactivity Following PCI

Cost-Effectiveness of Treating ACS Patients with Ticagrelor for 12 Months

Ticagrelor vs. Clopidogrel in Patients with ACS and a History of Stroke or TIA

Association of PPI Use and Cardiovascular Outcomes with Clopidogrel and Ticagrelor

Relaciones entre el uso de IBP y Desenlaces Cardiovasculares con Clopidogrel y Ticagrelor

Ticagrelor Enhances Adenosine-induced Coronary Vasodilatory Responses in Humans—a Randomised, Double-Blind, Placebo-Controlled, Crossover, Single Centre Study Using...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content